We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
National guidance, information and processes for the NHS fetal anomaly screening programme (FASP).
How to use the procedure for medicines licensing applications.
Patient group direction (PGD) template to support the national human papillomavirus (HPV) vaccination programme.
How to get state healthcare if you live, work or study in Greece.
Post exposure prophylaxis (PEP) is offered to individuals at high risk of severe chickenpox following an exposure.
Map outlining where ticks (Ixodes ricinus) are reported across England, Scotland and Wales.
Sets out medicines that can be moved to Northern Ireland to meet patient need.
Guidance to help applicants and licence holders get and maintain a wholesale dealer licence (WDA(H)) or broker registration – MHRA guidance note 6.
The purpose of this document is to support emerging health and wellbeing boards as they engage with the refresh of Joint Strategic Needs Assessments and develop their preparatory joint health and wellbeing strategy.
How to get state healthcare if you live, work or study in Germany.
This guidance clarifies the expectations on the application of the EU guidance on good pharmacovigilance practices (GVP)
An overview of the NHS diabetic eye screening (DES) programme, its services and contact information.
Practical help to support NHS organisations developing new safeguarding policies and procedures for female genital mutilation (FGM).
Guidance to help primary care, commissioners and local authorities plan and evaluate initiatives around cervical screening coverage in their area.
This document explains the Prostate Cancer Risk Management Programme (PCRMP), PSA testing and evidence against a national screening programme.
How mental health practitioners can manage risk including self-harm and harm to others.
Information resource for care home workers about preventing and controlling infection in care homes.
Details of the process changes for established medicines, effective from 1 March 2024, which apply specifically to chemical products.
Information explaining diabetic retinopathy, a disease screened for by the NHS diabetic eye screening (DES) programme.
Fees payable to the MHRA for 2023 to 2024
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).